CARL ANKRAH: Open Payments
NPI 1699935502 · BARDONIA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,320 in 62 payments from 13 companies in 2025. Trend: 2023 $1,058 · 2024 $1,775 · 2025 $2,320
Food & beverage: $2,245Education: $76
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 9 | $463 |
| ABBVIE INC. | 16 | $410 |
| Otsuka America Pharmaceutical, Inc. | 5 | $331 |
| E.R. Squibb & Sons, L.L.C. | 4 | $234 |
| Alkermes, Inc. | 10 | $210 |
| Teva Pharmaceuticals USA, Inc. | 2 | $192 |
| Viatris Specialty LLC | 1 | $122 |
| Lundbeck LLC | 5 | $110 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $99 |
| Axsome Therapeutics, Inc. | 2 | $49 |
Products named: VRAYLAR, INVEGA SUSTENNA, ABILIFY MAINTENA, COBENFY, ARISTADA, YUPELRI, UZEDY, CAPLYTA.
Industry payments across NY — which companies pay providers there.
